Zileuton

from Wikipedia, the free encyclopedia
Structural formula
Structure of Zileuton
1: 1 mixture of ( R ) -form (top) and ( S ) -form (bottom)
General
Non-proprietary name Zileuton
other names
  • ( RS ) -1- (1-Benzothiophen-2-ylethyl) -1-hydroxyurea
  • (±) -1- (1-Benzothiophen-2-ylethyl) -1-hydroxyurea
Molecular formula C 11 H 12 N 2 O 2 S
External identifiers / databases
CAS number 111406-87-2
EC number 601-087-3
ECHA InfoCard 100.121.111
PubChem 60490
DrugBank DB00744
Wikidata Q202998
Drug information
Drug class

Lipoxygenase inhibitor

properties
Molar mass 236.29 g · mol -1
Physical state

firmly

Melting point

157-158 ° C

safety instructions
GHS labeling of hazardous substances
07 - Warning

Caution

H and P phrases H: 302-319
P: ?
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

Zileuton is a 5-lipoxygenase inhibitor . It acts selectively and reversibly on 5-lipoxygenase , which produces leukotrienes LTA 4 , LTB 4 , LTC 4 , LTD 4 and LTE 4 released in the event of inflammation .

Zileuton is used in the USA as a medicinal substance for mild to moderate bronchial asthma . An effect is also expected against other inflammatory diseases, but this is still to be proven by studies.

In Germany there are no approved finished medicinal products with this active ingredient.

Individual evidence

  1. ^ The Merck Index : An Encyclopedia of Chemicals, Drugs, and Biologicals , 14th Edition (Merck & Co., Inc.), Whitehouse Station, NJ, USA, 2006; P. 1746, ISBN 978-0-911910-00-1 .
  2. Template: CL Inventory / not harmonized There is not yet a harmonized classification for this substance . A labeling of (RS) -N- [1- (1-benzothien-2-yl) ethyl] -N-hydroxyurea in the Classification and Labeling Inventory of the European Chemicals Agency (ECHA), retrieved on December 12, is reproduced from a self-classification by the distributor July 2020.
  3. ABDA database (as of June 18, 2008) of DIMDI .

Web links